Orthocell Ltd (ASX:OCC) managing director and CEO Paul Anderson gives Proactive an update on the company that has recently had it’s nerve repair device Remplir™ added to the Australian Prostheses list and gaining Australian reimbursement from private healthcare funds. Anderson discusses plans for expansion in the US and milestones coming up in the near future.
Orthocell’s Remplir™ added to Australian Prostheses list
